BackCarisma Therapeutics Overview

Carisma Therapeutics Other Current Assets

Latest other current assets for CARM: $3.1M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$3.09M
57.37% YoYΔ $-4.16M vs prior year quarter

Peer average / median

Loading

Carisma Therapeutics Other Current Assets History

Loading

Carisma Therapeutics vs. peers: Other Current Assets Comparison

Loading

Carisma Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Carisma Therapeutics (CARM) FAQ

Carisma Therapeutics (CARM) currently reports a other current assets of $3.1M as of September 2025. That compares with $7.3M in the prior-year period — down 57.4% year over year. Use the charts on this page to explore Carisma Therapeutics's other current assets history and peer comparisons.

Carisma Therapeutics's other current assets decreased from $7.3M to $3.1M — a 57.4% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Carisma Therapeutics reported $3.1M in other current assets as of September 2025. That compares with $7.3M in the prior-year period — down 57.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $3.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Carisma Therapeutics, and consider following CARM for alerts when major investors trade the stock.

Carisma Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $3.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CARM with unrelated industries.